Biotech Values

[Double_Bagel]

You’re hypothesizing that MNTA’s eight insiders* with 10b5-1 plans not only employ the same trading algorithm, but also that the algorithm happens to specify a significantly higher price threshold for a sale beginning on or about 9/1/12—a date with no particular relevance to MNTA’s compensation plans or business development. Possible, I suppose, but not likely.

p.s. Today marks 30 days without a 10b5-1 sale.

How many shares are sold on an average in these sales? I am trying to understand what amounts we are talking about. If it is usually about 5,000 shares then even if the buyout offer was at a 100% premium, we are only talking about netting an additional 75k. Is this a significant amount for multimillionaires? Is it worth tipping of outsiders for this amount of money?

Maybe if it is a higher number of shares sold each month and they expect the negotiation to take several months then it might make sense.